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Abstract: One of the most important chemicals used in the production of polymer plastics and
coatings is bisphenol A. However, despite the large number of studies on the toxicity and hormonal
activity of BPA, there are still open questions and thus considerable media attention regarding BPA
toxicity. Hence, it is necessary to develop a sensitive, simple, cost-efficient, specific, portable, and
rapid method for monitoring bisphenol A and for high sample throughput and on-site screening
analysis. Lateral flow immunoassays have potential as rapid tests for on-site screening. To meet
sensitivity criteria, they must be carefully optimized. A latex microparticle-based LFIA for detection
of BPA was developed. The sensitivity of the assay was improved by non-contact printing of spot
grids as the control and test lines with careful parameter optimization. Results of the test could be
visually evaluated within 10 min with a visual cut-off of 10 µg/L (vLOD). Alternatively, photographs
were taken, and image analysis performed to set up a calibration, which allowed for a calculated
limit of detection (cLOD) of 0.14 µg/L. The method was validated for thermal paper samples against
ELISA and LC–MS/MS as reference methods, showing good agreement with both methods.
Keywords: LFIA; immunoassay; bisphenol A; endocrine disruptor
1. Introduction
The rapid increase in the global population has accelerated the production of food,
industrial products, and also the need for service activities. This has, in turn, contributed
to the massive growth of the corresponding industrial sectors to meet the high demand for
goods of all kind. Another effect is that the number of chemicals used in consumer products
is steadily increasing, whereas understanding of human exposure to them and associated
human health risks often lag behind. Numerous studies on exposure to those chemicals
have proven adverse health effects both to humans and animals. Some of the substances
used in plastics production show effects on the hormone system and are therefore suspected
to contribute to various diseases.
Bisphenol A is one of the most important bulk chemicals in the world, used in the
production of polycarbonate plastics and epoxy-based resins. The global volume of BPA
use for different application areas is growing and expected to reach 10.6 million tons in
2022 [1]. However, despite the large number of studies on the toxicity and hormonal
activity of BPA [2–4], there are still open questions and thus considerable media attention
regarding BPA toxicity.
Many conventional analytical methods are very sensitive and accurate, yet technically
complex, time-consuming, require costly and sophisticated instrumentation, and do not
allow for field portability or high-throughput analysis [5–7]. The lateral flow immunoassay
is a user-friendly format in terms of simplicity and cost-effectiveness and allows for rapid
on-site testing [8].
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The publications on lateral flow immunoassays for quantitative detection of BPA
can be divided into four groups by their detection strategy (optical, thermal, magnetic,
electrochemical). Innovative materials have been employed in order to obtain a sensitive
and quantitative detection, e.g., special gold nanoparticles [9], a cadmium(II) porphyrin
modified carbon paste electrode [10], a black phosphorus/Au material [11], magnetic
nanoparticles [12], graphite-like carbon nitride-laden gold nanoparticles [13], and gold
nanoparticles with high SERS performance [14]. These amplification strategies have been
used as signaling probes to replace the gold nanoparticles and thus improve LFIA sensi-
tivity. However, operating with most of these materials and detection strategies requires
access to well-equipped, specialized laboratories and involves instrumental readers to
register the signal. Good overviews of advances in BPA detection by LFIA have been given
by Nguyen et al. (2016) [15] and Sun et al. (2002) [16].
In our study, we wanted to develop a simple LFIA for screening purposes that is easy
to produce and use.
Lateral flow methods based on latex microparticles decorated with antibodies (LMP-
IgG) offer several advantages, such as excellent visual evaluation due to intensely blue-
colored bands, long-term stability, inexpensiveness, and fair commercial availability [17].
In the present study, we have developed a low-cost, flexible, rapid, and easy-to-use
LFIA strip test based on latex microparticles decorated with an BPA-selective antibody
for determination of the endocrine disruptor bisphenol A. The analysis can be performed
within 10 min, evaluated by the naked eye or by taking a photograph and performing
image analysis. In our study, we developed a reproducible LFIA assay, which is cost
effective in terms of development and implementation and quantification of the results by
readily available software.
2. Materials and Methods
2.1. Chemicals
The LFIA test strips were cut using a paper cutter (Dahle 502, Novus Dahle GmbH,
Lingen, Germany). High-binding 96-well, flat-bottom microtiter plates (MaxiSorp™)
were from Nunc (Thermo Scientific, Waltham, MA, USA). PD-10 columns were from
GE Healthcare (Munich, Germany).
The anti-bisphenol A mouse monoclonal antibody was provided by the lab of Professor
Chuanlai Xu [18] (School of Food Science & Technology, State Key Lab of Food Science and
Technology, Jiangnan University, Wuxi, Jiangsu, China), dissolved in a PBS-based buffer
(7 mg/mL in 0.01 M PBS, pH 7.4, 1% BSA, 1% glycerol, 0.02% azide). The polyclonal goat
anti-mouse HRP-labeled antibody (clone A4416) (whole molecule, 0.5–3 mg/mL in 0.01 M
PBS, pH 7.4, 1% BSA, 0.02% azide) and sheep anti-mouse IgG, 0.6–2 mg/mL in 0.01 M PBS,
pH 7.4, 1% BSA, 0.02% azide) were provided by Merck Millipore (Darmstadt, Germany).
N-Hydroxysuccinimide (NHS), N-hydroxysulfosuccinimide (Sulfo-NHS), 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide * HCl (EDC), 2-(N-morpholino)ethanesulfonic acid
(MES), bovine serum albumin (BSA), bis-phenol A (BPA), bisphenol A-d16 (BPA-d16),
bisphenol valeric acid (BVA), bisphenol B (BPB), bisphenol E (BPE), bisphenol F (BPF),
bisphenol S (BPS), 4-cumylphenol (4-CP), 4-octylphenol (OCP), and 4-nonylphenol (4-
NP) were purchased from Merck KGaA (Darmstadt, Germany). Carboxyl-modified dyed
polystyrene microspheres (–COOH) K 030 with diameter 0.276–0.325 µm (dyed latex)
(Estapor®, product K1-030 blue) and ethanolamine were provided by Merck Millipore
(Darmstadt, Germany). Sample and adsorption pads (AP1002500) were provided by Merck
Millipore (Darmstadt, Germany). The nitrocellulose (NC) membrane, type CNPF, 10 µm,
the conjugate pad PT-R6, and the adhesion poly -vinyl chloride backing pad were obtained
from Advanced Microdevices PVT Ltd. (MDI, Ambala Cantt, India).
Absorbance in microtiter plates was measured photometrically with a SpectraMax®
Plus384 spectrophotometer from Molecular Devices (Ismaning, Germany) controlled by
SoftMax® Pro software (v 5.2). Microtiter plate washing was performed on an automatic
ELx405 Select™ microplate washer (BioTek Instruments, Bad Friedrichshall, Germany).
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Incubation steps for microtiter plates were performed by shaking on a Titramax 101 plate
shaker (Heidolph, Schwabach, Germany). All proteins were deposited onto the membrane
strips using a sciFLEXARRAYER S3 piezoelectric spotter (Scienion AG, Berlin, Germany).
Photographic images were taken with a Canon EOS 750D camera (Canon, Tokyo, Japan)
under an LED ring lamp (AIXPI, Shenzhen, China). Quantitative picture analysis of the
lateral flow immunoassay photographs was performed with the software Gwyddion (v2.19,
Czech Metrology Institute, http://gwyddion.net, accessed on 8 July 2021).
2.2. Preparation of the Hapten–Protein Conjugate
Since BPA does not have reactive functional groups, such as carboxylic or amino
groups, a commercially available reagent, 4,4-bis(4-hydroxyphenyl)valeric acid (BVA),
which is a structural analogue of BPA, was used as a mimotope. They have the same
antigenic determinant which, coupled to a protein, can mimic the epitope to which certain
anti-BPA antibodies will bind.
The hapten–protein conjugate was produced according to Schmidt et al. [19] with a
six-carbon aliphatic chain, which is considered to be the optimal spacer length for enabling
optimal binding. The synthesis of functionalized derivatives of the target compound is key
to increase the sensitivity of the assay [20]. For this purpose, aminohexanoic acid (Ahx) was
coupled with 4,4-bis(4-hydroxyphenyl) valeric acid (BVA). Briefly, BVA (26.3 mg) and NHS
(12.9 mg) were mixed with EDC (22.3 mg) and dissolved in 3 mL DMSO in an amber glass
vial, and the mixture was incubated with continuous stirring for 2 h at room temperature
under argon. Ahx (9.8 mg) was dissolved in 1.5 mL DMSO and was mixed with 1.5 mL
PBS (pH 6). Then, 2.5 mL of the reacted solution of BVA was added dropwise to the Ahx
solution and incubated for 4 h at room temperature. Because BVA-Ahx is not stable, the
carboxylic acid terminus was in situ activated by NHS/EDC chemistry as described above.
A total of 22 mg of BSA was dissolved in 2 mL PBS pH 6. The activated BVA-Ahx
was added dropwise to the protein solution. After 4 h reaction time, the protein conjugate
was purified via size-exclusion chromatography (SEC) on a PD-10 column, reaching a
final protein concentration of BVA-Ahx-BSA (Figure S1A) of 2.5 mg/mL, determined by
Bradford assay [21]. The efficiency of the conjugation reaction was verified by MALDI-ToF-
MS (Figure S1B).
2.3. Antibody Immobilization on Latex Microparticles
The preparation of the LMP-IgG conjugate was done using the protocol from our
previous work [22]. Briefly, to 1 mL of 50 mM MES coupling buffer of pH 6.0, 100 µL
of carboxy latex beads were added under stirring; subsequently, 24 µL of 200 mM EDC
and 240 µL of 200 mM Sulfo-NHS in 1 mL activation buffer (50 mM MES, pH 6.0) were
added [23]. After 30 min, the LMP were centrifuged at 14,000 rpm and 10 ◦C for 7 min, and
then the pellet was dispersed in 1 mL activation buffer. To fully disperse the particles, the
mixture was sonicated for 2 min. A varied amount of primary antibody stock solution was
added to the LMP dispersion and mixed gently. The dispersion was incubated 2.5 h at RT.
Then the quenching solution of 30 µL ethanolamine was added and incubated for 30 min.
The mixture was centrifuged at 14,000 rpm and 10 ◦C for 7 min. After centrifugation the
microparticles were resuspended in blocking buffer (50 mM Tris with 0.5% BSA, pH 8.0).
2.4. Assembly of Lateral Flow Test Strips
An LFIA strip consists of a nitrocellulose membrane (NC) with several pads: backing pad,
absorbent pad, conjugate pad, and sample pad. The configuration is shown in Figure 1. Onto
the NC membrane was deposited the hapten–protein conjugate BVA-Ahx-BSA in the test (T) line
zone, and sheep anti-mouse IgG was spotted into the control (C) line zone. An XYZ piezoelectric
non-contact spotter was used for this purpose [24]. The non-contact spotting protocol was
published by us previously [22]. Briefly, to create the lines with optimum width of the testing
zones of around 0.5–1.0 mm, several rows of spots spaced at a distance of 250 µm from each
other were applied. Each spot was formed from 40 droplets (each of 0.35 nL) (Tables S1 and S2).
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The space between test and control lines was 4 mm. The spotted membranes were dried for
1 h at 37 ◦C. To prevent any nonspecific binding, the membrane was blocked with 1% casein
in PBS for 10 min and washed twice with Milli-Q water and dried again for the next hour.
Finally, the conjugate pad was impregnated with 5 µL of latex microparticle antibody conjugate
(IgG−LMP). The conjugate pad had previously been treated with 20 mM borate buffer (BB) of
pH 8.2, containing 1% sucrose and 1% casein. The sample and absorbent pads were laminated
to the bottom and upper section of the adhesive backing pad with 2 mm overlap of the NC
membrane (Figure 1).
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Figure 1. Schematic image of detection of bisphenol A in lateral flow immunoassay.
2.5. Lateral Flow Immunoassay (LFIA)
The principle of the lateral flow method is based on the competitive binding of
bisphenol A from the sample or calibrator and the hapten–protein conjugate (BVA-Ahx-
BSA) on the test line (T) with the limited amount of anti-BPA antibodies on the particles
(LMP-IgG). If bisphenol A is absent in the sample, the hapten co jugate will capture the
antibody together with its particle payload, and this g nerat s a blue line, which can be
qualitatively judg d by the naked eye. Contrarily, if bisph ol A is present in the sample, it
will compete with the hapten conjugat BVA-Ahx-BSA for the limited number of antibody
b nding sites, leading to a decrease in i tensity of the blue line. Invariably, he secondary
antibodies in the control line zone will bind the LMP-IgG, creating a line, a control for the
validity of an individual run.
2.6. Lateral Flow Immunoassay Data Processing
C libration solutio s of bisphenol A were prepared from a 1 mg/mL stock solution in
ethanol by serial dilutions in Milli-Q water. The test strip was inserted into a well of the
microtiter plate with 100 µL of BPA calibrator or a real sample extract. After incubation
for 10 min at RT, the result was determined both by the naked eye and, after taking a
photograph, by the image analysis software Gwyddion (v 2.19) [25]. As shown in Figure 2a,
with increasing concentrations of bisphenol A, the color intensity of the test line decreased.
The nearest lower concentration of BPA providing still a visible coloration of the test line
was taken as the visual limit of detection (vLOD). The color intensity of the lines was
evaluated with the help of Gwyddion software (Figure 2b,c). The relation of color intensity
and BPA concentration was plotted to raise a calibration curve (Figure 2d). The equation
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where x is the analyte concentration and y the color intensity. A is the asymptotic max-
imum of the curve, D is the asymptotic minimum of the curve (background), C is the
respective concentration coordinate of the inflection point of the curve (similar to IC50,
the concentration where 50% reduction of the color intensity is reached), and B is a slope
parameter [26,27]. From the signal of a blank sample (without analyte), minus three times
the standard deviation of that signal the limit of detection was calculated based on three
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Figure 2. (a) Test strips with different concentration of BPA (in µg/L); (b) intensity profile of a test and control line and 
different concentrations of BPA; (c) evaluation of different test (T) line signals and baseline correction. The red horizontal 
line is the baseline for all signals (y2). The black horizontal line (at y1) is the example for concentration 0.001 µg/L (the 
maximal intensity (darkest) line, “Line max”, with the deepest intensity dip), the T Line Signal calculated as indicated by 
subtraction of the intensity values y2–y1 = 254 a.u. (d) Calibration curve obtained by plotting the mean of 3 replicates (n = 




Figure 2. (a) Test strips with different concentration of BPA (in µg/L); (b) intensity profile of a test and control line and
different concentrations of BPA; (c) evaluation of different test (T) line signals and baseline correction. The red horizontal
line is the baseline for all signals (y2). The black horizontal line (at y1) is the example for concentration 0.001 µg/L (the
maximal intensity (darkest) line, “Line max”, with the deepest intensity dip), the T Line Signal calculated as indicated by
subtraction of the intensity values y2–y1 = 254 a.u. (d) Calibration curve obtained by plotting the mean of 3 replicates (n = 3)
against BPA calibrator concentrations. The standard deviation (SD) was calculated from the replicates and is shown as
error bars.
2.7. Competitive indirect ELISA
Optimal dilutions of BVA-Ahx-BSA and anti-BPA mouse IgG, respectively, were de-
termined by checkerboard titration. Clear, high-binding microtiter plates were filled with
200 µL per well of the hapten–protein conjugate (BVA-Ahx-BSA) in PBS, pH 7.6. Coating
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was achieved by shaking with 750 rpm on an MTP shaker overnight at RT. After wash-
ing, the plates were blocked using casein in PBS (1%, w/v, 200 µL per well) for 1 h. The
plates were washed again, and 100 µL of sample or BPA standards and diluted anti-BPA
monoclonal IgG were added and incubated for 60 min. After a three-cycle washing step,
100 µL peroxidase-labeled goat anti-mouse IgG, diluted 1:20 000 in PBS, were added to
each well and incubated for 60 min. After another washing step, 8.5 µL H2O2 30% and
550 µL TMB solution (40 mM TMB/8 mM tetrabutylammonium borohydride in N,N′-
dimethylacetamide) were added to 22 mL of citrate buffer pH 4.0 (220 mM potassium
dihydrogen citrate, 0.5 mM sorbic acid potassium salt) as substrate solution, of which
100 µL were added to each well. After 20 min incubation, the reaction was stopped by
adding 100 µL/well of 1 M sulfuric acid. Between plate filling steps, washing steps were
performed with a washing buffer (phosphate-buffered saline, PBS, pH 7.6: 0.75 mM potas-
sium dihydrogen phosphate, 6.25 mM dipotassium hydrogen phosphate, 0.025 mM sorbic
acid potassium salt, 0.05% (v/v) Tween™ 20). Absorbance was measured photometrically
with the microplate reader at 450 nm and referenced to 620 nm.
2.8. Sample Preparation
Thermal paper samples (n = 3) were collected from local supermarkets of different
countries: Germany (Berlin), Belgium (Brussels), and Russia (Moscow). Other paper
products (n = 9) were collected mainly in Berlin in 2018 (see Table 3). These samples were
grouped into 3 categories: flyers (e.g., advertisement brochure from local restaurants),
tickets (e.g., train tickets), and food contact papers.
The extraction of bisphenol A was carried out by two methods. In the first method,
used for thermal receipt paper, 0.2 g of the thermal paper was inserted into 20 mL of
ethanol and stirred for one hour at 35 ◦C [28]. The second method (taken from [29]) was
used for flyers and magazines; 0.1 g of the sample was inserted into 2 mL of methanol and
extracted in an ultrasonic bath at 35 ◦C for ten minutes. The samples were first filtered to
remove the resulting dye coagulation and then cleaned with SPE for LC–MS/MS analysis,
following a protocol described in literature [30]. For the immunoassay, the solutions were
filtrated and diluted in Milli-Q water.
3. Results
The performance of different types of nitrocellulose (NC) membrane with different
pore sizes (8–15 µm) and different protein binding capacity (low, medium, high), respec-
tively, were evaluated. The CNPF 10 µm membrane was chosen for its good functionality
when compared with the other NC membranes. Spotting conditions of the membrane were
optimized. The influence of spotting parameters on the final characteristics of the assay
has been reported by us previously [22]. In this specific case, optimization improved the
limit of detection for BPA by a factor of roughly 100.
3.1. Analytical Characteristics of the LFIA
The results of the LFIA test strip can be evaluated by both the naked eye and by
photography and image analysis. Visual assessment is convenient for on-site analysis but
provides only a qualitative yes/no response around a threshold concentration (vLOD).
Moreover, the limit of detection determined by photography and image processing is much
lower than the cut-off concentration estimated by naked eye. The instrumental LOD is
calculated (-> cLOD) from the standard curve and the mean intensity of the test line for a
blank, as described above. Table 1 compares vLOD and cLOD.
Table 1. Parameters of visual and instrumental detection of BPA in the developed LFIA.
Visual Cut-Off,
vLOD, µg/L Instrumental Limit of Detection, cLOD, µg/L
10 0.14
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For quantification of the color intensity of test and control lines, the photographs
of the LFIA strips were processed with the image analysis software Gwyddion (v2.19)
(Figure 2). It works with 48-bit images, with intensity values (shades of grey) from 0 to
65,535, and automatically calculates the value in the area in question, which ensures an
automated quantitative analysis which is also user-friendly. A gray scale optical analysis
was performed from photographed images by the Canon camera under illumination by the
LED ring lamp, from which an area of the size 8 × 1.2 mm was selected for the analysis of
each image. The program has a function of automatically smoothing the data. The data can
be directly transferred to Origin® graphing and analysis software (Figure 2). In contrast
to ImageJ free image processing software (ImageJ, National Institute of Health; Bethesda,
MD, USA), Gwyddion software allows for the quick processing of large amounts of test
strips because of the implemented algorithms for data analysis. ImageJ does not provide
these functions, and data processing can only be done manually by using, for example, the
software Origin.
3.2. Selectivity of the Antibody
Immunoassay selectivity was tested by assaying several compounds structurally
related to bisphenol A (Table 2). The specificity of the monoclonal antibody and selectivity
of the assay was evaluated [31] by determining their IC50 values (midpoints, parameter C
in the 4-parametric sigmoidal fitting curve~half maximum inhibitory concentration) and
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4. Discussion
Under optimized conditions, this latex microparticle-based LFIA allowed BPA to be
visually detected at 10 µg/L (vLOD). Image analysis-based quantification resulted in an
LOD (cLOD) of 0.14 µg/L.
Cross-reactivity studies, involving structurally related compounds like BVA, 4-CP,
BPE, BPF, and BPS, revealed a high selectivity of the used antibody to BPA. Abstraction of
methyl groups and hydroxyl groups of the bisphenol A structure results in a pronounced
drop in cross-reactivity, while the extension of the methyl group by an additional carbon
in the case of bisphenol B (BPB) resulted in a cross-reactivity of about 200%. High cross-
reactivity of bisphenol B can be explained by the higher similarity of the compound to
the antigen used for immunization. That antibody was most probably produced from
BVA directly coupled to a carrier protein to obtain an immunogen. When structurally
simpler phenolic compounds, such as 4-octylphenol (OCP) and 4-nonylphenol (4-NP) were
evaluated, the color of the test line in the test strip appeared to be of the same intensity as
that of the negative control sample. This was assigned a cross-reactivity of <0.1%.
Lateral flow immunoassays, such as our assay, rely on the recognition/binding of the
analyte by antibodies produced via immunization of mammals. Recent work described the
interesting approach of detecting bisphenol A through analyzing, by RT-PCR, the expression
by a recombinant E. coli, modified with a recA promoter [32], and another work reported the
production of a transgenic A. thaliana strain that carries the estrogen receptor to which BPA
can bind, and an anthocyanin reporter system for indicating this binding [33]. These biosensor
developments are very promising, yet mostly lack sensitivity, compared to antibody-based
systems. A very comparable signal-enhanced LFIA was proposed by Peng et al. [34], with a
comparable vLOD of 10 µg/L; yet the cLOD, after picture analysis by ImageJ software, reached
only 2 µg/L. An LFIA described by Dzantiev et al. [35], employing latex particles, reached a
comparable vLOD (5 µg/L). By read-out with a flat-bed scanner, an astonishingly more than
10.000-fold lower instrumental LOD of 0.3 ng/L was obtained.
An application, to test for BPA release from coated papers, was set up. It involved
as samples thermal receipt paper, public transportation tickets, flyers, and food contact
papers (Table 3). Validation was done against ELISA and LC–MS/MS as reference methods,
with good agreement of the methods. The results of LC–MS/MS and ELISA reflect the
progressing ban of BPA use in thermal receipt papers and food contact papers: the latter
was free of BPA. The receipts of two countries were “clean” while a receipt from a third
country showed around 0.7 µg/L in the extract. The LFIA was not able to detect this low
concentration. The extracts of tickets and flyers all contained between 14 and 52 µg/L BPA.
Table 3. Analytical results of selected samples (n = 3 replicates). The values of BPA found with LC–MS/MS, ELISA, and LFIA are
shown. Information in brackets indicates the recovery rate (BPA in relation to LC–MS/MS) of the immunoassays.











Thermal receipt paper #1 0.70 ± 0.03 <LOD − 0.76 ± 0.2(108) 18
Thermal receipt paper #2 <LOD <LOD − <LOD −
Thermal receipt paper #3 <LOD <LOD − <LOD −
Tickets #1 14 ± 1.2 15 ± 10(109) 6
17 ± 2.1
(125) 12
Tickets #2 34 ± 2.3 29 ± 10(83) 8
43 ± 1.6
(126) 9
Flyers #3 47 ± 3.0 50 ± 7.1(105) 10
52 ± 4.4
(110) 11
Food contact papers <LOD <LOD − <LOD −
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An additional result, not reflected in Table 3, was, that LC–MS/MS analysis revealed
that the extracts of some thermal paper samples contained high concentrations of BPS (ca.
270–780 µg/L) (Figure S4), which sometimes substitutes BPA in its applications.
5. Conclusions
To our knowledge, this is the first work reporting the development of a latex-microparticle-
based LFIA technique for the detection of BPA. Moreover, a new hapten–protein conjugate,
including a C6 spacer (Ahx), was employed in conjunction with a commercially available
anti-BPA antibody.
The latex microparticle-based LFIA allowed BPA to be visually detected at 10 µg/L
(vLOD). In contrast, photo image analysis-based quantification resulted in an LOD (cLOD)
of 0.14 µg/L. This limit of detection is far below the current Specific Migration Limit set for
bisphenol A by the European Commission (600 µg/L).
Validation results showed a satisfactory performance of the LFIA for a screening
application, which also revealed the substitution of BPA by BPS. Considering the toxicity
of bis-phenol S and the fact that there are studies on the release from food cans [36,37], but
that little is known about transfer rates of BPS from paper to skin, further studies on BPS
release from different materials is recommended.
This lateral flow immunoassay is simple and rapid and could be used for simultane-
ously analyzing a large number of samples. Additionally, the method is inexpensive and
highly portable, allowing for on-site analysis, e.g., for the consumer’s own testing for BPA
release.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/bios11070231/s1: (1) Characterization of BVA-Ahx-BSA; (2) Optimization of spotting; (3)
Verification of the reaction of BVA with Ahx and formation of BVA-Ahx; (4) ELISA performance; (5)
Chromatograms to detect BPA and BPS. With Figures S1–S4.
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